Abstract
BackgroundChimeric antigen receptor (CAR) T cells have shown great efficacy in treating hematological malignancies. Nonetheless, in solid tumors CAR T cells have yet to demonstrate significant clinical efficacy. In solid...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
